Providers advised to halt use, monitor patients, and report any complications with BioZorb devices to the FDA.
Dr. Rick Lehman performs the MACI procedure, which uses the patient's own cells to regrow cartilage in the knee, eliminating ...
October 2024 brought 4 new FDA drug approvals in the oncology space. With new drug regimens in both the solid tumor and blood ...
Abbott (NYSE:ABT) announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging ...
Ataluren is a protein restoration agent designed to enable the formation of a functioning protein in patients with nonsense mutation.
Scemblix (asciminib) is a new first-line option for adults with newly diagnosed Philadelphia chromosome-positive chronic ...
The U.S. Food and Drug Administration has warned users of Skin-Cap aerosol spray that there may be undisclosed steroids in ...
FDA staff raised familiar safety concerns about sotagliflozin as a treatment for type 1 diabetes (T1D) as the agency again ...